Craxì A - Search Results

1

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma.

Cammà C, Cabibbo G, Petta S, Enea M, Iavarone M, Grieco A, Gasbarrini A, Villa E, Zavaglia C, Bruno R, Colombo M, Craxì A; WEF study group; SOFIA study group. Cammà C, et al. Among authors: craxi a. Hepatology. 2013 Mar;57(3):1046-54. doi: 10.1002/hep.26221. Epub 2013 Feb 12. Hepatology. 2013. PMID: 23299720

2

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Cammà C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxì A, Cottone M. Cammà C, et al. Among authors: craxi a. Radiology. 2002 Jul;224(1):47-54. doi: 10.1148/radiol.2241011262. Radiology. 2002. PMID: 12091661 Review.

3

Recent progress and new trends in the treatment of hepatitis B.

Alberti A, Brunetto MR, Colombo M, Craxì A. Alberti A, et al. Among authors: craxi a. J Med Virol. 2002 Jul;67(3):458-62. doi: 10.1002/jmv.10097. J Med Virol. 2002. PMID: 12116046

4

When and how to treat acute hepatitis C?

Licata A, Di Bona D, Schepis F, Shahied L, Craxí A, Cammà C. Licata A, et al. Among authors: craxi a. J Hepatol. 2003 Dec;39(6):1056-62. doi: 10.1016/s0168-8278(03)00461-6. J Hepatol. 2003. PMID: 14642626

5

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G. Pollicino T, et al. Among authors: craxi a. Gastroenterology. 2004 Jan;126(1):102-10. doi: 10.1053/j.gastro.2003.10.048. Gastroenterology. 2004. PMID: 14699492

6

Interferon-alpha for HBeAg-positive chronic hepatitis B.

Craxì A, Di Bona D, Cammà C. Craxì A, et al. J Hepatol. 2003;39 Suppl 1:S99-105. doi: 10.1016/s0168-8278(03)00154-5. J Hepatol. 2003. PMID: 14708686 Review. No abstract available.

7

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.

Cammà C, Di Bona D, Schepis F, Heathcote EJ, Zeuzem S, Pockros PJ, Marcellin P, Balart L, Alberti A, Craxì A. Cammà C, et al. Among authors: craxi a. Hepatology. 2004 Feb;39(2):333-42. doi: 10.1002/hep.20073. Hepatology. 2004. PMID: 14767986

8

The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach.

Cammà C, Di Bona D, Craxì A. Cammà C, et al. Among authors: craxi a. Curr Pharm Des. 2004;10(17):2123-30. doi: 10.2174/1381612043384321. Curr Pharm Des. 2004. PMID: 15279551 Review.

9

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial.

Bruno S, Cammà C, Di Marco V, Rumi M, Vinci M, Camozzi M, Rebucci C, Di Bona D, Colombo M, Craxì A, Mondelli MU, Pinzello G. Bruno S, et al. Among authors: craxi a. J Hepatol. 2004 Sep;41(3):474-81. doi: 10.1016/j.jhep.2004.05.012. J Hepatol. 2004. PMID: 15336451 Clinical Trial.

10

Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine.

Di Marco V, Marzano A, Lampertico P, Andreone P, Santantonio T, Almasio PL, Rizzetto M, Craxì A; Italian Association for the Study of the Liver (AISF) Lamivudine Study Group, Italy. Di Marco V, et al. Among authors: craxi a. Hepatology. 2004 Oct;40(4):883-91. doi: 10.1002/hep.20381. Hepatology. 2004. PMID: 15382125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters